Paul Steven M Insider Trades

Insider Trading History

Track insider trading activity for Paul Steven M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Rapport Therapeutics
Rapport Therapeutics RAPP
Director
Holding Value $1.56M 41,666 shares
Last Trade
Sep 12, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.03M 41,666 shares
$24.65
$37.49
Rapport Therapeutics
Rapport Therapeutics RAPP
Director
Holding Value $819k 21,850 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 21,850 shares
$10.95
$37.49
Karuna Therapeutics
Karuna Therapeutics KRTX
Director
Holding Value $2.82M 8,550 shares
Last Trade
Mar 18, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$693M 2,101,633 shares
$329.83
$329.83
Karuna Therapeutics
Karuna Therapeutics KRTX
Director
Holding Value $10M 30,304 shares
Last Trade
Mar 04, 2024 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$9.64M 30,304 shares
$318.24
$329.83
Karuna Therapeutics
Karuna Therapeutics KRTX
Director
Holding Value $13.3M 40,304 shares
Last Trade
Mar 01, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$9.58M 30,304 shares
$316.24
$329.83
Karuna Therapeutics
Karuna Therapeutics KRTX
Director
Holding Value $10.8M 32,668 shares
Last Trade
Mar 01, 2024 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$9.58M 30,304 shares
$316.24
$329.83
Karuna Therapeutics
Karuna Therapeutics KRTX
Director
Holding Value $23.3M 70,608 shares
Last Trade
Feb 29, 2024 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$14.9M 47,378 shares
$315.18
$329.83
Karuna Therapeutics
Karuna Therapeutics KRTX
Director
Holding Value $250M 757,045 shares
Last Trade
Feb 23, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.1M 31,518 shares
$320.25
$329.83
Karuna Therapeutics
Karuna Therapeutics KRTX
Director
Holding Value $13.9M 42,114 shares
Last Trade
Feb 23, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.1M 31,518 shares
$320.25
$329.83
Karuna Therapeutics
Karuna Therapeutics KRTX
Director
Holding Value $3.49M 10,596 shares
Last Trade
Feb 09, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$255k 804 shares
$317.14
$329.83
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $34.5k 3,971 shares
Last Trade
Jan 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.1k 3,971 shares
$21.67
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $86.8k 10,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$561k 10,000 shares
$56.10
$8.68
Karuna Therapeutics
Karuna Therapeutics KRTX
CSO And President Of R&d
Holding Value $7.52M 22,800 shares
Last Trade
Feb 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.27M 22,800 shares
$187.26
$329.83
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $20.8k 2,395 shares
Last Trade
Jan 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$93.8k 2,395 shares
$39.16
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $682k 78,539 shares
Last Trade
Nov 28, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$191 5 shares
$38.17
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $86.3k 9,947 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$312k 9,947 shares
$31.36
$8.68
Karuna Therapeutics
Karuna Therapeutics KRTX
CSO And President Of R&d
Holding Value $35.1M 106,485 shares
Last Trade
May 31, 2022 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$11.1M 106,485 shares
$104.32
$329.83
Karuna Therapeutics
Karuna Therapeutics KRTX
CSO And President Of R&d
Holding Value $0 0 shares
Last Trade
May 31, 2022 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$11.1M 106,485 shares
$104.32
$329.83
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $4.86M 16,000 shares
Last Trade
Apr 01, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.54M 15,000 shares
$169.29
$303.64
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $4.78M 15,747 shares
Last Trade
Apr 01, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$42k 253 shares
$166.04
$303.64

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up